4.8 Article

Mutations in Chromatin Modifier and Ephrin Signaling Genes in Vein of Galen Malformation

Journal

NEURON
Volume 101, Issue 3, Pages 429-+

Publisher

CELL PRESS
DOI: 10.1016/j.neuron.2018.11.041

Keywords

-

Categories

Funding

  1. Yale-NIH Center for Mendelian Genomics [5U54HG006504]
  2. NIH NRCDP award
  3. James Hudson Brown-Alexander Brown Coxe postdoctoral fellowship
  4. American Heart Association postdoctoral fellowship
  5. Howard Hughes Institute medical research fellowship

Ask authors/readers for more resources

Normal vascular development includes the formation and specification of arteries, veins, and intervening capillaries. Vein of Galen malformations (VOGMs) are among the most common and severe neonatal brain arterio-venous malformations, shunting arterial blood into the brain's deep venous system through aberrant direct connections. Exome sequencing of 55 VOGM probands, including 52 parent-offspring trios, revealed enrichment of rare damaging de novo mutations in chromatin modifier genes that play essential roles in brain and vascular development. Other VOGM probands harbored rare inherited damaging mutations in Ephrin signaling genes, including a genome-wide significant mutation burden in EPHB4. Inherited mutations showed incomplete penetrance and variable expressivity, with mutation carriers often exhibiting cutaneous vascular abnormalities, suggesting a two-hit mechanism. The identified mutations collectively account for similar to 30% of studied VOGM cases. These findings provide insight into disease biology and may have clinical implications for risk assessment.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available